Zobrazeno 1 - 10
of 127
pro vyhledávání: '"Nosha, Farhadfar"'
Publikováno v:
In Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology September 2024 36(5):749-753
Autor:
Joseph Pidala, Paul A Carpenter, Lynn Onstad, Steven Z Pavletic, Betty K Hamilton, George L Chen, Nosha Farhadfar, Marcie Hall, Stephanie J Lee
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0298026 (2024)
Chronic graft-versus-host disease (GVHD) is an immune-mediated disorder that causes significant late morbidity and mortality following allogeneic hematopoietic cell transplantation. The "Close Assessment and Testing for Chronic GVHD (CATCH)" study is
Externí odkaz:
https://doaj.org/article/0ced38d2ce7a4db196f394077f4d1b82
Autor:
Nosha Farhadfar, Jeni Newman, Jennifer Novakovich, Jacklyn Barten, Eric T. Ndifon, Jason Oakes, Meghann Cody, Huy P. Pham, Jeffery J. Auletta, John P. Miller, Steven M. Devine, Heather E. Stefanski
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundThe Coronavirus Disease 2019 (COVID-19) pandemic in early 2020 has resulted in an unprecedented level of uncertainty and challenge for the stem cell donor registries. To address these challenges, rapid strategies were implemented by the Nat
Externí odkaz:
https://doaj.org/article/5aaa790c19104fba96094110ade32492
Publikováno v:
SAGE Open Medical Case Reports, Vol 10 (2022)
Oral squamous cell carcinoma is a potential long-term complication after hematopoietic stem cell transplantation. This may be related to mechanisms including radiation and chemotherapy regimens, chronic graft-versus-host disease, inflammation, and pr
Externí odkaz:
https://doaj.org/article/273c6e87a70f44cb97756e59ddcca9b3
Autor:
Matthew Mei, Raju Pillai, Soyoung Kim, Noel Estrada-Merly, Michelle Afkhami, Lixin Yang, Zhuo Meng, Muhammad Bilal Abid, Mahmoud Aljurf, Ulrike Bacher, Amer Beitinjaneh, Christopher Bredeson, Jean-Yves Cahn, Jan Cerny, Edward Copelan, Corey Cutler, Zachariah DeFilipp, Miguel Angel Diaz Perez, Nosha Farhadfar, César O. Freytes, Shahinaz M. Gadalla, Siddhartha Ganguly, Robert Peter Gale, Usama Gergis, Michael R. Grunwald, Betty K. Hamilton, Shahrukh Hashmi, Gerhard C. Hildebrandt, Hillard M. Lazarus, Mark Litzow, Reinhold Munker, Hemant S. Murthy, Sunita Nathan, Taiga Nishihori, Sagar S. Patel, David Rizzieri, Sachiko Seo, Mithun Vinod Shah, Melhem Solh, Leo F. Verdonck, Ravi Vij, Ronald M. Sobecks, Betul Oran, Bart L. Scott, Wael Saber, Ryotaro Nakamura
Publikováno v:
Haematologica, Vol 108, Iss 1 (2022)
Somatic mutations are recognized as an important prognostic factor in chronic myelomonocytic leukemia (CMML). However, limited data are available regarding their impact on outcomes after allogeneic hematopoietic cell transplantation (HCT). In this re
Externí odkaz:
https://doaj.org/article/23076c7290164061a98b071548e28beb
Autor:
Narendranath Epperla, Kwang W. Ahn, Carlos Litovich, Sairah Ahmed, Minoo Battiwalla, Jonathon B. Cohen, Parastoo Dahi, Nosha Farhadfar, Umar Farooq, Cesar O. Freytes, Nilanjan Ghosh, Bradley Haverkos, Alex Herrera, Mark Hertzberg, Gerhard Hildebrandt, David Inwards, Mohamed A. Kharfan-Dabaja, Farhad Khimani, Hillard Lazarus, Aleksandr Lazaryan, Lazaros Lekakis, Hemant Murthy, Sunita Nathan, Taiga Nishihori, Attaphol Pawarode, Tim Prestidge, Praveen Ramakrishnan, Andrew R. Rezvani, Rizwan Romee, Nirav N. Shah, Ana Sureda, Timothy S. Fenske, Mehdi Hamadani
Publikováno v:
Journal of Hematology & Oncology, Vol 12, Iss 1, Pp 1-11 (2019)
Abstract Background There is a paucity of data on the role of allogeneic hematopoietic cell transplantation (allo-HCT) in patients with angioimmunoblastic T-cell lymphoma (AITL). Using the CIBMTR registry, we report here the outcomes of AITL patients
Externí odkaz:
https://doaj.org/article/19ce45d9a24347588db685661d8cf472
Autor:
Guru Subramanian Guru Murthy, Brent R. Logan, Stephanie Bo‐Subait, Amer Beitinjaneh, Steven Devine, Nosha Farhadfar, Lohith Gowda, Shahrukh Hashmi, Hillard Lazarus, Sunita Nathan, Akshay Sharma, Jean A. Yared, Heather E. Stefanski, Michael A. Pulsipher, Jack W. Hsu, Galen E. Switzer, Sandhya R. Panch, Bronwen E. Shaw
Publikováno v:
American Journal of Hematology. 98:608-619
Allogeneic hematopoietic cell transplantation (allo-HCT) is a potentially curative treatment for acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). While many factors influence the outcomes of allo-HCT, the independent impact of don
Autor:
Nirav N. Shah, Kwang Woo Ahn, Carlos Litovich, Timothy S. Fenske, Sairah Ahmed, Minoo Battiwalla, Nelli Bejanyan, Parastoo B. Dahi, Javier Bolaños-Meade, Andy I. Chen, Stefan O. Ciurea, Veronika Bachanova, Zachariah DeFilipp, Narendranath Epperla, Nosha Farhadfar, Alex F. Herrera, Bradley M. Haverkos, Leona Holmberg, Nasheed M. Hossain, Mohamed A. Kharfan-Dabaja, Vaishalee P. Kenkre, Hillard M. Lazarus, Hemant S. Murthy, Taiga Nishihori, Andrew R. Rezvani, Anita D'Souza, Bipin N. Savani, Matthew L. Ulrickson, Edmund K. Waller, Anna Sureda, Sonali M. Smith, Mehdi Hamadani
Publikováno v:
Blood Advances, Vol 2, Iss 8, Pp 933-940 (2018)
Abstract: The application of allogeneic hematopoietic cell transplantation (allo-HCT) in non-Hodgkin lymphoma (NHL) patients ≥65 years in the United States is limited by lack of Medicare coverage for this indication. Using the Center for Internatio
Externí odkaz:
https://doaj.org/article/e1f7f92829604e7783e85b8341e07274
Autor:
Amy E DeZern, Mary Eapen, Juan Wu, Julie-An Talano, Melhem Solh, Blachy J Dávila Saldaña, Chatchada Karanes, Mitchell E Horwitz, Kanwaldeep Mallhi, Sally Arai, Nosha Farhadfar, Elizabeth Hexner, Peter Westervelt, Joseph H Antin, H Joachim Deeg, Eric Leifer, Robert A Brodsky, Brent R Logan, Mary M Horowitz, Richard J Jones, Michael A Pulsipher
Publikováno v:
Lancet Haematol
Relapsed severe aplastic anaemia is a marrow failure disorder with high morbidity and mortality. It is often treated with bone marrow transplantation at relapse post-immunosuppressive therapy, but under-represented minorities often cannot find a suit
Autor:
Ally Fraser, Paul Castillo, Erika Cascio, Giselle Moore‐Higgs, Nosha Farhadfar, John Fort, William Slayton, Jatinder Lamba, Biljana Horn
Publikováno v:
Pediatric Blood & Cancer. 70